Genasys Inc. Reports Fiscal Second Quarter 2024 Financial Results
Increased Scope in Puerto Rico Expands Opportunity to $75 million CROWS 16 Program Established SAN DIEGO, May 14, 2024 (GLOBE […]
Genasys Announces Expansion of Its Board of Directors
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications, today announced […]
Genasys Announces $15 Million Two-Year Term Loan Agreement
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications, today announced […]
Fiverr to Present at Upcoming Conference
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) — Fiverr International Ltd, (NYSE: FVRR), the company that is changing how the […]
AEON Biopharma Reports First Quarter 2024 Financial Results
– Ongoing analysis of interim data from the Phase 2 study of ABP-450 in chronic migraine, which did not achieve […]
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary […]
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of […]
QIAGEN erhält europäische IVDR-Zertifizierung für seine Medizinprodukte-Software zur Unterstützung der klinischen Entscheidungsfindung QIAGEN Clinical Insight Interpret
VENLO, Niederlande, May 14, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass […]
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated […]
Jones Soda Reports First Quarter 2024 Results
SEATTLE, May 14, 2024 (GLOBE NEWSWIRE) — Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), a […]
